Resultados da pesquisa - (( j et champ can ngoc ) OR ((( _ pet compared law nw ) OR ( j health company law new ))))

Pesquisas alternativas:
ngoc » ngo (Expandir a Pesquisa)

1

Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive

Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive

Por Gray, Richard T., Watson, Jo, Cogle, Aaron J., Smith, Don E., Hoy, Jennifer F., Bastian, Lisa A., Finlayson, Robert, Drummond, Fraser M., Whittaker, Bill, Law, Matthew G., Petoumenos, Kathy
Publicado no Sex Health (2018)

“...BACKGROUND: The aim of this study is to estimate the reduction in new HIV infections and resultant...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

A tolerability assessment of new respiratory protective devices developed for health care personnel: A randomized simulated clinical study

A tolerability assessment of new respiratory protective devices developed for health care personnel: A randomized simulated clinical study

Por Radonovich, Lewis J., Wizner, Kerri, LaVela, Sherri L., Lee, Martin L., Findley, Kimberly, Yorio, Patrick
Publicado no PLoS One (2019)

“.... health care marketplace. The purpose of this study was to compare the tolerability of four new prototype...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Pharmacovigilance in pharmaceutical companies: An overview

Pharmacovigilance in pharmaceutical companies: An overview

Por Mammì, Maria, Citraro, Rita, Torcasio, Giovanni, Cusato, Gennaro, Palleria, Caterina, di Paola, Eugenio Donato
Publicado em 2013

“... measures in order to improve the operation of Union law on the pharmacovigilance of medicinal products...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions

Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions

Por Frybourg, Sandrine, Remuzat, Cécile, Kornfeld, Åsa, Toumi, Mondher
Publicado no J Mark Access Health Policy (2015)

“... professionals and companies and covers a vast range of health products. Commercial sales agreements of goods...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Regulating pharmaceutical companies’ financial largesse

Regulating pharmaceutical companies’ financial largesse

Por Avraham, Ronen, Silver, Charles
Publicado no Isr J Health Policy Res (2018)

“... National Health Insurance Law that requires annual reporting of payments from pharmaceutical companies (PCs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Closing the Regulatory Gap for Synthetic Nicotine Products

Closing the Regulatory Gap for Synthetic Nicotine Products

Por Zettler, Patricia J., Hemmerich, Natalie, Berman, Micah L.
Publicado no Boston Coll Law Rev (2018)

“...In July 2017 the U.S. Food and Drug Administration (FDA) announced a new “comprehensive plan...”
Obter o texto integral
Obter o texto integral

Artigo

7

Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies

Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies

Por Van Norman, Gail A.
Publicado no JACC Basic Transl Sci (2018)

“...Individual patients with life-threatening or severely debilitating diseases can petition the U.S...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities

Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities

Por Gupta, Sandeep Kumar, Nayak, Roopa Prasad
Publicado em 2014

“... to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

AB 9. Health management of occupational diseases challenge for the bulgarian economy and public health

AB 9. Health management of occupational diseases challenge for the bulgarian economy and public health

Por Filippidou, Elisabeth-Christina, Lyubomirova, Karolina, Tzacheva, Nevena
Publicado em 2012

“... introduced a new system of reporting and recording Occupational illness into practice. In 2009 more than...”
Obter o texto integral
Obter o texto integral

Artigo

10

A NEW METHOD FOR THE TURBIDIMETRIC MEASUREMENT OF BACTERIAL DENSITY

A NEW METHOD FOR THE TURBIDIMETRIC MEASUREMENT OF BACTERIAL DENSITY

Por Kurokawa, Masami, Hatano, Motoichi, Kashiwagi, Noboru, Saito, Tateo, Ishida, Setsuji, Homma, Reiko
Publicado em 1962

“...Kurokawa, Masami (National Institute of Health, Tokyo, Japan), Motoichi Hatano, Noboru Kashiwagi...”
Obter o texto integral
Obter o texto integral

Artigo

11

A Corporate Veto on Health Policy? Global Constitutionalism and Investor-State Dispute Settlement

A Corporate Veto on Health Policy? Global Constitutionalism and Investor-State Dispute Settlement

Por Hawkins, Benjamin, Holden, Chris
Publicado no J Health Polit Policy Law (2016)

“... public health. The multiplicity of new veto points in this global ‘spaghetti bowl’ of IIAs creates...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

Regulatory chills: tobacco industry legal threats and the politics of tobacco standardised packaging in New Zealand

Regulatory chills: tobacco industry legal threats and the politics of tobacco standardised packaging in New Zealand

Por Crosbie, Eric, Thomson, George
Publicado no N Z Med J (2018)

“... reviewed. Policymakers and health advocates in New Zealand were interviewed. The data were triangulated...”
Obter o texto integral
Obter o texto integral

Artigo

13

Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs

Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs

Por Skipka, Guido, Wieseler, Beate, Kaiser, Thomas, Thomas, Stefanie, Bender, Ralf, Windeler, Jürgen, Lange, Stefan
Publicado no Biom J (2016)

“... between the umbrella organization of statutory health insurance and the pharmaceutical companies....”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Expressive Freedom and Tobacco Advertising: A Canadian Perspective

Expressive Freedom and Tobacco Advertising: A Canadian Perspective

Por Manfredi, Christopher P.
Publicado em 2002

Assuntos: “...Government, Politics, and Law: Tobacco Advertising and the Supreme Court...”
Obter o texto integral
Obter o texto integral

Artigo

15

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry

Por Rémuzat, Cécile, Toumi, Mondher, Falissard, Bruno
Publicado no J Mark Access Health Policy (2013)

“... as by two laws that came into force in December 2011. This new environment has been described and analyzed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Genetic Testing Integration Panels (GTIPs): A novel approach for considering integration of direct-to-consumer and other new genetic tests into patient care

Genetic Testing Integration Panels (GTIPs): A novel approach for considering integration of direct-to-consumer and other new genetic tests into patient care

Por Uhlmann, Wendy R., Sharp, Richard R.
Publicado em 2012

“... direct-to-consumer (DTC) companies and several offer tests not considered standard of care. To address...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Comparing the place of experts during the first waves of the COVID-19 pandemic

Comparing the place of experts during the first waves of the COVID-19 pandemic

Publicado no Stockholm Studies in Romance Languages (2024)

Assuntos: “...Media studies; Social psychology; Social representations; Sociology of experts; Sociology of health...”
Obter o texto integral

Livro

18

Chapter Determinants of social startups in Italy

Chapter Determinants of social startups in Italy

Por Palazzo, Lucio, Sabatino, Pietro, Ievoli, Riccardo
Publicado no Proceedings e report (2021)

Assuntos: “...bic Book Industry Communication::J Society & social sciences::JH Sociology & anthropology::JHB...”
Obter o texto integral

Livro

19

The Haverstraw Experience: The First Tobacco Product Display Ban in the United States

The Haverstraw Experience: The First Tobacco Product Display Ban in the United States

Por Curry, Laurel E., Schmitt, Carol L., Juster, Harlan
Publicado em 2014

“... in the United States. Community groups funded by the New York State Department of Health Tobacco Control Program...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Work-Related Stress Risk Assessment in Italy: A Methodological Proposal Adapted to Regulatory Guidelines

Work-Related Stress Risk Assessment in Italy: A Methodological Proposal Adapted to Regulatory Guidelines

Por Persechino, Benedetta, Valenti, Antonio, Ronchetti, Matteo, Rondinone, Bruna Maria, Di Tecco, Cristina, Vitali, Sara, Iavicoli, Sergio
Publicado em 2013

“... of occupational health professionals in each company. The assessment tools provided enable companies not only...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo